doi: 10.1159/000231192.
Immediate hypersensitivity in the guinea pig conjunctiva. I. Characterisation of the IgE and IgG1 antibodies involved
- PMID: 4842788
- DOI: 10.1159/000231192
Item in Clipboard
Immediate hypersensitivity in the guinea pig conjunctiva. I. Characterisation of the IgE and IgG1 antibodies involved
Int Arch Allergy Appl Immunol.
1974.
No abstract available
Similar articles
-
Immediate hypersensitivity in the guinea pig conjunctiva. III. long-term persistence of the hypersensitive state and characterization of antibodies.Int Arch Allergy Appl Immunol. 1981;65(1):102-6. doi: 10.1159/000232744. Int Arch Allergy Appl Immunol. 1981. PMID: 7012038
-
Heterogeneity of guinea-pig homocytotropic antibodies.Immunology. 1972 May;22(5):915-23. Immunology. 1972. PMID: 4401794 Free PMC article.
-
The biologic activities of guinea pig antibodies. I. Separation of gamma1 and gamma2 immunoglobulins and their participation in allergic reactions of the immediate type.J Immunol. 1970 Feb;104(2):320-8. J Immunol. 1970. PMID: 4189669 No abstract available.
-
Chemotaxis of eosinophil leukocytes in relation to immediate-type hypersensitivity and the complement system.Antibiot Chemother (1971). 1974;19:271-83. Antibiot Chemother (1971). 1974. PMID: 4142850 Review. No abstract available.
-
[Modern views on anaphylaxis as a form of the manifestation of body reactivity].Zh Mikrobiol Epidemiol Immunobiol. 1982 Jul;(7):9-14. Zh Mikrobiol Epidemiol Immunobiol. 1982. PMID: 6750997 Review. Russian. No abstract available.
Cited by
-
The ability of salbutamol and theophylline to suppress immediate allergic conjunctivitis in the guinea pig.Graefes Arch Clin Exp Ophthalmol. 1987;225(5):331-4. doi: 10.1007/BF02153399. Graefes Arch Clin Exp Ophthalmol. 1987. PMID: 3666475
-
Anti-allergic properties of a new coumarin compound (BM 15,100) [proceedings].Br J Pharmacol. 1976 Jul;57(3):438P. Br J Pharmacol. 1976. PMID: 10033 Free PMC article. No abstract available.
-
Allergic conjunctivitis and uveitis models: reappraisal with some marketed drugs.Inflamm Res. 1995 Jan;44(1):47-54. doi: 10.1007/BF01630487. Inflamm Res. 1995. PMID: 7664029